[1] |
TORRE LA, SIEGEL RL, JEMAL A. Lung cancer statistics[J]. Adv Exp Med Biol, 2016, 893: 1. |
[2] |
REDDY KB. MicroRNA(miRNA) in cancer[J]. Cancer Cell Int, 2015, 15(1): 38. doi: 10.1186/s12935-015-0185-1 |
[3] |
WANG C, DING M, XIA M, et al. A five-miRNA panel identified from a multicentric case-control study serves as a novel diagnostic tool for ethnically diverse non-small-cell lung cancer patients[J]. Bio Medicine, 2015, 2(10): 1377. doi: 10.1016/j.ebiom.2015.07.034 |
[4] |
FRANCHINA T, AMODEO V, BRONTE G, et al. Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non-small cell lung cancer[J]. J Cell Physiol, 2014, 229(1): 97. |
[5] |
MATIKAS A, SYRIGOS KN, AGELAKI S. Circulating biomarkers in non-small-cell lung cancer: current status and future challenges[J]. Clin Lung Cancer, 2016, 17(6): 507. doi: 10.1016/j.cllc.2016.05.021 |
[6] |
STEFANI G, SLACK FJ. Small non-coding RNAs in animal development[J]. Nat Rev Mol Cell Bio, 2008, 9(3): 219. doi: 10.1038/nrm2347 |
[7] |
BOYERINAS B, PARK SM, HAU A, et al. The role of let-7 in cell differentiation and cancer[J]. Endocrine-Related Cancer, 2010, 17(1): F19. doi: 10.1677/ERC-09-0184 |
[8] |
YE Y, LI X, YANG Q, et al. The role of microRNA in human lung squamous cell carcinoma[J]. Cancer Genet Cytogenet, 2010, 200(2): 127. doi: 10.1016/j.cancergencyto.2010.03.014 |
[9] |
ZHONG Z, DONG Z, YANG L, et al. Inhibition of proliferation of human lung cancer cells by green tea catechins is mediated by upregulation of let-7[J]. Exp Ther Med, 2012, 4(2): 267. doi: 10.3892/etm.2012.580 |
[10] |
ZHAN M, QU Q, WANG G, et al. Let-7c inhibits NSCLC cell proliferation by targeting HOXA1[J]. APJCP, 2013, 14(1): 387. doi: 10.7314/APJCP.2013.14.1.387 |
[11] |
中国临床肿瘤学会血管靶向治疗专家委员会, 非小细胞肺癌专家委员会, 非小细胞肺癌抗血管生成药物治疗专家组. 晚期非小细胞肺癌抗血管生成药物治疗中国专家共识(2019版)[J]. 中国肺癌杂志, 2019, 22(7): 401. |
[12] |
BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394. doi: 10.3322/caac.21492 |
[13] |
何圆, 尤长宣. 非小细胞肺癌免疫治疗进展[J]. 中国肺癌杂志, 2014, 17(3): 277. |
[14] |
张娣, 黄架旗, 张初峰, 等. PD-1/PD-L1免疫检查点抑制剂在肺癌中的研究进展[J]. 中国肺癌杂志, 2019, 22(6): 366. |
[15] |
尚学琴, 阎婷婷, 杨眉, 等. 肺癌组织中Let-7的表达及意义[J]. 广东医学, 2018, 39(7): 983. |
[16] |
董峰, 马君俊, 孙晶, 等. miR-124a、let-7表达与胃癌临床病理特征和化疗疗效的相关性[J]. 现代生物医学进展, 2018, 18(24): 4643. |
[17] |
喻箴, 肖明耀, 崔明, 等. Let-7在正常乳腺组织和乳腺癌组织中的表达[J]. 昆明医科大学学报, 2016, 37(7): 19. |
[18] |
FASSINA A, CAPPELLESSO R, FASSAN M. Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling[J]. Chest, 2011, 140(5): 1305. doi: 10.1378/chest.11-0708 |
[19] |
ZHAO B, HAN H, CHEN J, et al. MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3[J]. Cancer Letters, 2014, 342(1): 43. doi: 10.1016/j.canlet.2013.08.030 |
[20] |
耿淼, 潘静坤, 罗芸, 等. miRNA Let-7与乳腺癌预后的相关性分析[J]. 局解手术学杂志, 2019, 28(1): 1. |
[21] |
ZHU X, WU L, YAO J, et al. MicroRNA let-7c inhibits cell proliferation and induces cell cycle arrest by targeting CDC25A in human hepatocellular carcinoma[J]. PLoS One, 2015, 10(4): e0124266. doi: 10.1371/journal.pone.0124266 |
[22] |
IZZOTTI A, CALIN GA, ARRIGO P, et al. Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke[J]. Faseb J, 2009, 23(3): 806. doi: 10.1096/fj.08-121384 |
[23] |
李玉梅, 刘静, 周争光, 等. 培美曲塞与吉西他滨联合顺铂一线治疗晚期非小细胞肺癌的对比研究[J]. 蚌埠医学院学报, 2018, 43(6): 719. |
[24] |
YANG Z, LIU C, WU H, et al. CSB affected on the sensitivity of lung cancer cells to platinum-based drugs through the global decrease of let-7 and miR-29[J]. BMC Cancer, 2019, 19(1): 948. doi: 10.1186/s12885-019-6194-z |
[25] |
MEIRAV S, ANNABELLE B, MAUD-EMMANUELLE G, et al. Hydrophobically modified let-7b miRNA enhances biodistribution to NSCLC and downregulates HMGA2 in vivo[J]. Mol Ther Nucleic Acids, 2020, 19: 267. doi: 10.1016/j.omtn.2019.11.008 |
[26] |
ZHOU Y, LIANG H, LIAO Z, et al. MIR-203 enhances let-7 biogenesis by targeting LIN28B to suppress tumor growth in lung cancer[J]. Sci Rep, 2017, 7: 42680. doi: 10.1038/srep42680 |
[27] |
YIN J, HU W, PAN L, et al. Let-7 and miR-17 promote self-renewal and drive gefitinib resistance in non-small cell lung cancer(Article)[J]. Oncol Rep, 2019, 42(2): 495. doi: 10.3892/or.2019.7197 |
[28] |
CHEN Y, XIE C, ZHENG X, et al. LIN28/let-7/PD-L1 pathway as a target for cancer immunotherapy[J]. Cancer Immunol Res, 2019, 7(3): 487. doi: 10.1158/2326-6066.CIR-18-0331 |
[29] |
GILLES ME, SLACK FJ. Let-7 microRNA as a potential therapeutic target with implications for immunotherapy[J]. Expert Opin Ther Targets, 2018, 22(11): 929. doi: 10.1080/14728222.2018.1535594 |
[30] |
LI XX, DI X, CONG S, et al. The role of let-7 and HMGA2 in the occurrence and development of lung cancer: a systematic review and meta-analysis[J]. Eur Rev Med Pharmacol Sci, 2018, 22(23): 8353. doi: 10.26355/eurrev_201812_16533 |